Clinical spectrum of Kufor-Rakeb syndrome in the Chilean kindred with ATP13A2 mutations
- PMID: 20683840
- DOI: 10.1002/mds.22996
Clinical spectrum of Kufor-Rakeb syndrome in the Chilean kindred with ATP13A2 mutations
Abstract
We report the clinical features of the original Chilean family with Kufor-Rakeb syndrome (KRS) that led to the discovery of the ATP13A2 gene at the PARK9 locus. KRS is a rare juvenile-onset autosomal recessive disease characterized by progressive Parkinsonism, pyramidal signs, and cognitive decline in addition to vertical gaze palsy and facial-faucial-finger minimyoclonus. Neurological and neuropsychological examination during a 10-year period, videotaping, neuroimaging, and measurement of DNA methylation of the ATP13A2 promoter region were performed. The youngest 5 of 17 children of nonconsanguineous parents, carrying compound-heterozygous ATP13A2 mutations, had normal development until ages ∼10 to 12 years, when school performance deteriorated and slowness, rigidity, and frequent falls developed. Examination revealed bradykinesia, subtle postural/action tremor, cogwheel rigidity, spasticity, upward gaze palsy, smooth pursuit with saccadic intrusions, and dementia. Additional signs included facial-faucial-finger minimyoclonus, absent postural reflexes, visual/auditory hallucinations, and insomnia. Levodopa response could not be fully judged in this family. T2* magnetic resonance imaging sequences revealed marked diffuse hypointensity of the caudate (head and body) and lenticular nucleus bilaterally. Disease progression was slow including epilepsy, cachexia, and anarthria. Four affected members died after 28.5 ± 5.5 (mean ± SD) years of disease. Two heterozygous carriers, the mother and eldest sibling, showed jerky perioral muscle contractions and clumsiness of hand movements. There was no significant correlation between DNA methylation of the ATP13A2 promoter region and disease progression. The marked caudate and lenticular nucleus T2*-hypointensity suggests that KRS might belong to the family of neurodegenerative diseases associated with brain iron accumulation.
© 2010 Movement Disorder Society.
Similar articles
-
Clinical and ultrastructural findings in an ataxic variant of Kufor-Rakeb syndrome.Folia Neuropathol. 2019;57(3):285-294. doi: 10.5114/fn.2019.88459. Folia Neuropathol. 2019. PMID: 31588715
-
Recessively inherited parkinsonism: effect of ATP13A2 mutations on the clinical and neuroimaging phenotype.Arch Neurol. 2010 Nov;67(11):1357-63. doi: 10.1001/archneurol.2010.281. Arch Neurol. 2010. PMID: 21060012
-
Hereditary Parkinsonism-Associated Genetic Variations in PARK9 Locus Lead to Functional Impairment of ATPase Type 13A2.Curr Protein Pept Sci. 2017;18(7):725-732. doi: 10.2174/1389203717666160311121534. Curr Protein Pept Sci. 2017. PMID: 26965689 Review.
-
Altered apoptosis regulation in Kufor-Rakeb syndrome patients with mutations in the ATP13A2 gene.J Cell Mol Med. 2012 Aug;16(8):1916-23. doi: 10.1111/j.1582-4934.2011.01488.x. J Cell Mol Med. 2012. PMID: 22117566 Free PMC article.
-
Mutations in the ATP13A2 gene and Parkinsonism: a preliminary review.Biomed Res Int. 2014;2014:371256. doi: 10.1155/2014/371256. Epub 2014 Aug 14. Biomed Res Int. 2014. PMID: 25197640 Free PMC article. Review.
Cited by
-
Common pathogenic effects of missense mutations in the P-type ATPase ATP13A2 (PARK9) associated with early-onset parkinsonism.PLoS One. 2012;7(6):e39942. doi: 10.1371/journal.pone.0039942. Epub 2012 Jun 29. PLoS One. 2012. PMID: 22768177 Free PMC article.
-
Estimation of Ambulation and Survival in Neurodegeneration with Brain Iron Accumulation Disorders.Mov Disord Clin Pract. 2024 Jan;11(1):53-62. doi: 10.1002/mdc3.13933. Epub 2023 Dec 1. Mov Disord Clin Pract. 2024. PMID: 38291840 Free PMC article.
-
Genetic Evidence for Endolysosomal Dysfunction in Parkinson's Disease: A Critical Overview.Int J Mol Sci. 2023 Mar 28;24(7):6338. doi: 10.3390/ijms24076338. Int J Mol Sci. 2023. PMID: 37047309 Free PMC article. Review.
-
Genetics and Pathophysiology of Neurodegeneration with Brain Iron Accumulation (NBIA).Curr Neuropharmacol. 2013 Jan;11(1):59-79. doi: 10.2174/157015913804999469. Curr Neuropharmacol. 2013. PMID: 23814539 Free PMC article.
-
Mutant Atp13a2 proteins involved in parkinsonism are degraded by ER-associated degradation and sensitize cells to ER-stress induced cell death.Hum Mol Genet. 2011 Sep 15;20(18):3565-77. doi: 10.1093/hmg/ddr274. Epub 2011 Jun 10. Hum Mol Genet. 2011. PMID: 21665991 Free PMC article.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Molecular Biology Databases